EMBL Australia

Associate Professor Max Cryle is an EMBL Australia Group Leader, based at the Monash Biomedicine Discovery Institute.

EMBL Australia group leader A/Prof Mikaël Martino and Victorian node head Prof Peter Currie will use a grant of more than $820,000 from the Medical Research Future Fund's Stem Cell Therapies Mission to improve the lives of those with muscular dystrophies & myopathies.

Two EMBL Australia group leaders have been awarded close to $2 million in funding for their innovative projects under the Australian Research Council’s Future Fellowships scheme.

New research from an EMBL Australia group leader outlines a novel method of enhancing regenerative activity, with clinical implications on improving the effectiveness of growth factor-based therapies.

News this quarter:

• Our group leaders join the global battle against COVID-19
• Leap forward in the generation of new antibiotics
• New genomics centre to open under David Lynn’s leadership
• Prof Peter Currie elected as Fellow of the Science Academy
• Gene research could lead to cancer breakthrough
• Annual student symposium EAPS to go virtual in 2020
• Emerging leader wins grant for basic research on enzymes
• Get to Know: Professor David Lynn

And more:

• Job opportunities
• Student opportunities
• Recent publications

The international research community is collaborating on a scale and at a speed never seen before to battle COVID-19 and EMBL Australia group leaders have answered the call to help.

EMBL Australia group leader Professor David Lynn will be the interim director of a new $7 million state-of-the-art centre for genomics in South Australia that he played a vital role in championing.

Professor David Lynn is an EMBL Australia Group Leader, based at the South Australian Health and Medical Research Institute (SAHMRI), and a Flinders University Professor.

EMBL Australia group leader Max Cryle has provided a new understanding of Glycopeptide antibiotics (GPAs) biosynthesis that allows new GPAs to be made and tested in the laboratory - a vital step in the quest to develop new antibiotics to keep pace with the ever-evolving ‘superbugs’ that threaten global public health.

An opinion article by EMBL Australia Scientific Head Professor James Whisstock (published in The Herald Sun on 13 May 2020) calls for a national approach for funding a diversity and depth of scientific research we hope we might never need.